A. Leyva
- Physiology top 2%
- Adenosine and Purinergic Signaling 8
- Oncology top 5%
- Molecular Biology top 10%
- Biochemical and Molecular Research 23
- Cancer therapeutics and mechanisms 5
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 5
- Hematology top 5%
-
- HIV/AIDS drug development and treatment 13
-
- Acute Lymphoblastic Leukemia research 8
-
- Chronic Lymphocytic Leukemia Research 6
-
- Cytomegalovirus and herpesvirus research 5
- Co-authors
- Herbert M. PinedoGodefridus J. PetersWilliam N. KelleyA. VeermanRob PietersD. R. HuismansE. LaurensseEmile J. Laurensse
- Cited by
- PhysiologyOncologyMolecular Biology
- Journals
- Advances in experimental medicine and biology (6 papers)Cancer Letters (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- NetherlandsUnited StatesBrazil
In The Last Decade
A. Leyva
72 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 113
- Physiology 112
- Oncology 647
- Molecular Biology 1.1k
- Cancer Research 215
- Hematology 159
Countries citing papers authored by A. Leyva
This map shows the geographic impact of A. Leyva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Leyva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Leyva more than expected).
Fields of papers citing papers by A. Leyva
This network shows the impact of papers produced by A. Leyva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Leyva. The network helps show where A. Leyva may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. Leyva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Las arvenses y su entomofauna asociada en el cultivo del frijol (Phaseolus vulgaris, L.) posterior al periodo crítico de competencia | 2013 | 1 |
| 2 | Los Dominios de Recomendaciones: Establecimiento e importancia para el análisis científico de los agroecosistemas | 2008 | 2 |
| 3 | 2000 | 43 | |
| 4 | Diversidad de cultivos agrícolas en el municipio de Jaruco | 1999 | 1 |
| 5 | 1999 | 23 | |
| 6 | 1993 | 52 | |
| 7 | 1989 | 8 | |
| 8 | 1989 | 24 | |
| 9 | 1989 | 107 | |
| 10 | 1989 | 16 | |
| 11 | 1988 | 124 | |
| 12 | 1988 | 3 | |
| 13 | 1988 | 60 | |
| 14 | 1988 | 30 | |
| 15 | 1988 | 13 | |
| 16 | 1987 | 32 | |
| 17 | 1987 | 72 | |
| 18 | 1987 | 10 | |
| 19 | 1987 | 48 | |
| 20 | 1984 | 31 |
About A. Leyva
A. Leyva is a scholar working on Physiology, Infectious Diseases and Biochemistry, having authored 74 papers that have together received 1.8k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (23 papers), HIV/AIDS drug development and treatment (13 papers), Adenosine and Purinergic Signaling (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer therapeutics and mechanisms (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Physiology (112 citations), Oncology (647 citations) and Molecular Biology (1.1k citations). A. Leyva has collaborated with scholars based in Netherlands, United States and Brazil. Frequent co-authors include Herbert M. Pinedo, Godefridus J. Peters, William N. Kelley, A. Veerman, Rob Pieters, D. R. Huismans, E. Laurensse, Emile J. Laurensse, Jan Lankelma and J. Lankelma. Their work appears in journals such as Advances in experimental medicine and biology, Cancer Letters, Cancer Chemotherapy and Pharmacology, Biochemical Pharmacology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.